ProMIS Neurosciences Inc.

NASDAQ: PMN · Real-Time Price · USD
0.61
-0.02 (-3.17%)
At close: Aug 15, 2025, 3:59 PM
0.61
0.41%
After-hours: Aug 15, 2025, 07:17 PM EDT

ProMIS Neurosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
8.36M 13.29M 21.54M 992.46K 3.38M 16.69M 22.91M 1.62M 4.5M 7.96M 5.42M 11.46M 13.75M 21.43M 26.56M 6.92M 8.78M
Short-Term Investments
33.05K 33.05K 32.36K 32.36K 43.83K 61.64K 69.88K 59.69K 59.58K 59.46K 59.73K 59.59K 49.41K 50.69K 65.77K 42.06K 42K
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 393.38
Other Long-Term Assets
n/a n/a n/a n/a n/a 195.63K n/a n/a n/a 0.38 -0.35 0.51 0.16 0.38 n/a 2.00 0.62
Receivables
54.56K 78.03K 630.28K 72.25K 76.81K 78.64K n/a n/a 41.52K 71.63K n/a 56.42K 100.81K n/a 166.34K 55.03K n/a
Inventory
n/a n/a n/a n/a -76.81K -78.64K -165.51K -46.25K -41.52K -71.63K -60.71K -56.42K -80.64K -48.69K -1.27 -55.03K -189.37K
Other Current Assets
22.45K 5.13M 12.99K 30.77K 23.53K 566.62K 341.54K 176.02K 470.3K 4.62K 857.72K 178.42K 419.07K 4.39K 152.99K 13.25K n/a
Total Current Assets
13.65M 18.91M 24.51M 1.31M 4.81M 18.04M 24.26M 1.96M 5.96M 9.35M 7.4M 13.08M 14.41M 22.4M 29.18M 7.72M 9.26M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a 434.62 1.09K 3.57K 5.01K 5.91K 60.35K 72.49K 85.95K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a 24.48K 24.96K 26.58K 28.21K 30.02K 31.61K 26.65K 34.92K 36.69K 38.31K 39.92K
Total Long-Term Assets
n/a n/a n/a 99.56K n/a 195.63K 24.48K 24.96K 26.58K 28.65K 31.1K 35.19K 31.66K 40.83K 97.03K 110.8K 126.27K
Total Assets
13.65M 18.91M 24.51M 1.41M 4.81M 18.04M 24.28M 1.98M 5.98M 9.38M 7.43M 13.12M 14.44M 22.44M 29.28M 7.83M 9.38M
Account Payables
1.2M 1.74M 1.58M 2.02M 1.4M 10.39M 8.41M 7.96M 6.99M 2.98M 1.79M 888.01K 644.75K 408.98K 453.74K 233.3K 241.79K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
421.52K n/a n/a n/a n/a n/a 49.00 -2.84M n/a -1.05M n/a n/a n/a 0.00 1.47M 491.3K 1.87M
Total Current Liabilities
4.06M 2.22M 2.64M 3.17M 3.58M 12.39M 13.38M 11.58M 11.77M 8.68M 4.28M 2.41M 1.39M 1.17M 2.2M 1.17M 2.23M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.05M 4.94M 4.84M 4.57M 4.5M
Other Long-Term Liabilities
118.69K 204.85K 14.6M 514.72K 825.29K 516.19K 1.27M 1.29M 1.9M 1.86M 1.55M 1.61M 5.27M 9.17M 12.6M 7.09M 11.33M
Total Long-Term Liabilities
118.69K 204.85K 14.6M 514.72K 825.29K 516.19K 1.27M 1.29M 1.9M 1.86M 1.55M 1.61M 9.31M 14.11M 17.44M 15.47M 15.83M
Total Liabilities
4.17M 2.42M 17.24M 3.69M 3.58M 12.39M 13.38M 11.58M 11.77M 8.68M 4.28M 2.41M 10.7M 15.28M 19.64M 16.64M 18.06M
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.05M 4.94M 4.84M 4.57M 4.5M
Common Stock
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 46.16M 56.51M 71.61M 53.59M 53.51M
Retained Earnings
-98.03M -90.69M -90.45M -99.72M -131.53M -123.84M -122.09M -115.95M -115.17M -108.66M -100.81M -86.29M -64.29M -78.64M -80.26M -79.2M -78.78M
Comprehensive Income
-371.18K -371.18K -371.18K -371.18K -502.78K -491.81K -504.16K -491.72K -269.93K -264.52K -373.35K -178.21K -140.08K -237.63K 8.66M 8.28M 8.1M
Shareholders Equity
9.47M 16.49M 7.27M -2.28M 104.43K 4.97M 9.17M -11.3M -8.35M -1.82M 1.01M 8.64M 3.74M 7.16M 9.64M -8.81M -8.68M
Total Investments
33.05K 33.05K 32.36K 32.36K 43.83K 61.64K 69.88K 59.69K 59.58K 59.46K 59.73K 59.59K 49.41K 50.69K 65.77K 42.06K 42.39K